[Form 4] Evolus, Inc. Insider Trading Activity
Insider sale under 10b5-1 plan: Tomoko Yamagishi-Dressler, Chief Marketing Officer and director at Evolus, Inc. (EOLS), reported the sale of 5,722 shares of the company's common stock on 08/22/2025 at a price of $7.51 per share. After the transaction, the reporting person beneficially owned 89,949 shares. The filing indicates the sale was made pursuant to a Rule 10b5-1 trading plan and that the shares sold were required to be sold to cover tax withholding obligations arising from the vesting of restricted stock units.
Form and signature: The Form 4 was executed by an attorney-in-fact on behalf of the reporting person and includes the standard certification language required by Section 16 filings.
Vendita da insider in base al piano 10b5-1: Tomoko Yamagishi-Dressler, Chief Marketing Officer e amministratore di Evolus, Inc. (EOLS), ha comunicato la vendita di 5.722 azioni della societ脿 in data 22/08/2025 al prezzo di $7,51 per azione. Dopo l'operazione, la persona che ha presentato la comunicazione deteneva beneficiariamente 89.949 azioni. La segnalazione specifica che la vendita 猫 avvenuta ai sensi di un piano di negoziazione secondo la Rule 10b5-1 e che le azioni vendute erano necessarie per coprire obblighi fiscali derivanti dal consolidamento di restricted stock units.
Modulo e firma: Il modulo Form 4 猫 stato firmato da un procuratore in nome della persona che ha presentato la comunicazione e contiene la consueta dichiarazione di certificazione richiesta per le comunicazioni ai sensi della Sezione 16.
Venta de insider bajo un plan 10b5-1: Tomoko Yamagishi-Dressler, directora y Chief Marketing Officer de Evolus, Inc. (EOLS), inform贸 la venta de 5.722 acciones ordinarias de la compa帽铆a el 22/08/2025 a $7,51 por acci贸n. Tras la transacci贸n, la persona informante pose铆a beneficiariamente 89.949 acciones. La presentaci贸n indica que la venta se realiz贸 conforme a un plan de negociaci贸n bajo la Regla 10b5-1 y que las acciones vendidas fueron necesarias para cubrir retenciones fiscales derivadas del otorgamiento de unidades de acciones restringidas (RSU).
Formulario y firma: El Formulario 4 fue ejecutado por un apoderado en nombre de la persona informante e incluye el lenguaje de certificaci贸n est谩ndar exigido para las presentaciones conforme a la Secci贸n 16.
10b5-1 瓿勴殟鞐� 霐半ジ 雮措秬鞛� 毵る弰: Evolus, Inc.(EOLS)鞚� 斓滉碃毵堨紑韺呾眳鞛勳瀽 瓴� 鞚挫偓鞚� Tomoko Yamagishi-Dressler電� 2025雲� 8鞗� 22鞚� 須岇偓 氤错喌欤� 5,722欤茧ゼ 欤茧嫻 $7.51鞐� 毵る弰頃� 靷嫟鞚� 氤搓碃頄堨姷雼堧嫟. 瓯半灅 頉� 氤搓碃鞚胳潃 89,949欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 毵る弰臧� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 鞚措（鞏挫鞙茧┌, 毵る弰霅� 欤检嫕鞚� 鞝滍暅臁瓣贝攵� 欤检嫕 雼渼(RSU)鞚� 臧�霌濎溂搿� 氚滌儩頃� 靹戈笀 鞗愳矞歆曥垬 鞚橂毳� 於╇嫻頃橁赴 鞙勴暣 韺愲Г霅� 瓴冹瀯鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
靹滌嫕 氚� 靹滊獏: Form 4電� 氤搓碃鞚胳潉 雽�鞁犿暣 雽�毽澑鞚� 靹滊獏頄堨溂氅� 靹轨厴 16 鞝滌稖鞐� 鞖旉惮霅橂姅 響滌 鞚胳 氍戈惮臧� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Vente d'initi茅 dans le cadre d'un plan 10b5-1聽: Tomoko Yamagishi-Dressler, directrice marketing et administratrice d'Evolus, Inc. (EOLS), a d茅clar茅 avoir vendu 5聽722 actions ordinaires de la soci茅t茅 le 22/08/2025 au prix de 7,51 $ par action. Apr猫s la transaction, la personne d茅clarant d茅tenait b茅n茅ficiairement 89聽949 actions. Le d茅p么t indique que la vente a 茅t茅 effectu茅e conform茅ment 脿 un plan de transaction en vertu de la r猫gle 10b5-1 et que les actions vendues devaient l'锚tre pour couvrir des obligations fiscales r茅sultant de l'attribution de restricted stock units.
Formulaire et signature聽: Le formulaire Form 4 a 茅t茅 sign茅 par un mandataire agissant au nom de la personne d茅clarant et contient la formule de certification standard requise pour les d茅p么ts en vertu de la Section 16.
Insider-Verkauf nach 10b5-1-Plan: Tomoko Yamagishi-Dressler, Chief Marketing Officer und Direktorin von Evolus, Inc. (EOLS), meldete den Verkauf von 5.722 Stammaktien des Unternehmens am 22.08.2025 zu je $7,51. Nach der Transaktion hielt die meldende Person wirtschaftlich 89.949 Aktien. Die Meldung weist darauf hin, dass der Verkauf im Rahmen eines Rule 10b5-1-Handelsplans erfolgte und die verkauften Aktien zur Deckung von Steuerabzugsverpflichtungen aus dem Vesting von Restricted Stock Units verkauft werden mussten.
Formular und Unterschrift: Das Formular Form 4 wurde von einem Bevollm盲chtigten im Namen der meldenden Person ausgef眉hrt und enth盲lt die 眉blichen Best盲tigungsformulierungen, die f眉r Meldungen nach Section 16 erforderlich sind.
- Sale was conducted under a Rule 10b5-1 trading plan, indicating it was prearranged and not opportunistic trading
- Clear disclosure of amounts and price: 5,722 shares sold at $7.51, leaving 89,949 shares beneficially owned
- Sale purpose explicitly stated as covering tax withholding for vested restricted stock units
- Insider reduced holdings by 5,722 shares, which lowers the reporting person's direct stake
- Transaction occurred at $7.51, which may be below or above current market levels (market context not provided in filing)
Insights
TL;DR: A routine, prearranged sale of 5,722 shares under a 10b5-1 plan to satisfy tax withholding; holding remains material at 89,949 shares.
The transaction is explicitly described as effected under a Rule 10b5-1 trading plan and tied to tax withholding for vested restricted stock units, which signals a non-discretionary, pre-planned disposition rather than opportunistic insider trading. The sale amount (5,722 shares at $7.51) and resulting beneficial ownership (89,949 shares) are disclosed clearly, meeting Section 16 transparency requirements. This is a standard executive liquidity event and does not, on its face, indicate a change in company fundamentals.
TL;DR: Disclosure aligns with governance best practices: use of 10b5-1 plan and timely Form 4 filing; signature executed by attorney-in-fact.
The filing documents: reporter role (Officer/CMO and Director), the specific share amount sold, price per share, and the pro forma beneficial ownership after the sale. The explanation states the sale covered tax withholding from vested RSUs and was executed under an approved 10b5-1 plan, which supports procedural compliance. Execution by an attorney-in-fact is noted and the form contains the required certification language.
Vendita da insider in base al piano 10b5-1: Tomoko Yamagishi-Dressler, Chief Marketing Officer e amministratore di Evolus, Inc. (EOLS), ha comunicato la vendita di 5.722 azioni della societ脿 in data 22/08/2025 al prezzo di $7,51 per azione. Dopo l'operazione, la persona che ha presentato la comunicazione deteneva beneficiariamente 89.949 azioni. La segnalazione specifica che la vendita 猫 avvenuta ai sensi di un piano di negoziazione secondo la Rule 10b5-1 e che le azioni vendute erano necessarie per coprire obblighi fiscali derivanti dal consolidamento di restricted stock units.
Modulo e firma: Il modulo Form 4 猫 stato firmato da un procuratore in nome della persona che ha presentato la comunicazione e contiene la consueta dichiarazione di certificazione richiesta per le comunicazioni ai sensi della Sezione 16.
Venta de insider bajo un plan 10b5-1: Tomoko Yamagishi-Dressler, directora y Chief Marketing Officer de Evolus, Inc. (EOLS), inform贸 la venta de 5.722 acciones ordinarias de la compa帽铆a el 22/08/2025 a $7,51 por acci贸n. Tras la transacci贸n, la persona informante pose铆a beneficiariamente 89.949 acciones. La presentaci贸n indica que la venta se realiz贸 conforme a un plan de negociaci贸n bajo la Regla 10b5-1 y que las acciones vendidas fueron necesarias para cubrir retenciones fiscales derivadas del otorgamiento de unidades de acciones restringidas (RSU).
Formulario y firma: El Formulario 4 fue ejecutado por un apoderado en nombre de la persona informante e incluye el lenguaje de certificaci贸n est谩ndar exigido para las presentaciones conforme a la Secci贸n 16.
10b5-1 瓿勴殟鞐� 霐半ジ 雮措秬鞛� 毵る弰: Evolus, Inc.(EOLS)鞚� 斓滉碃毵堨紑韺呾眳鞛勳瀽 瓴� 鞚挫偓鞚� Tomoko Yamagishi-Dressler電� 2025雲� 8鞗� 22鞚� 須岇偓 氤错喌欤� 5,722欤茧ゼ 欤茧嫻 $7.51鞐� 毵る弰頃� 靷嫟鞚� 氤搓碃頄堨姷雼堧嫟. 瓯半灅 頉� 氤搓碃鞚胳潃 89,949欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 毵る弰臧� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 鞚措（鞏挫鞙茧┌, 毵る弰霅� 欤检嫕鞚� 鞝滍暅臁瓣贝攵� 欤检嫕 雼渼(RSU)鞚� 臧�霌濎溂搿� 氚滌儩頃� 靹戈笀 鞗愳矞歆曥垬 鞚橂毳� 於╇嫻頃橁赴 鞙勴暣 韺愲Г霅� 瓴冹瀯鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
靹滌嫕 氚� 靹滊獏: Form 4電� 氤搓碃鞚胳潉 雽�鞁犿暣 雽�毽澑鞚� 靹滊獏頄堨溂氅� 靹轨厴 16 鞝滌稖鞐� 鞖旉惮霅橂姅 響滌 鞚胳 氍戈惮臧� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Vente d'initi茅 dans le cadre d'un plan 10b5-1聽: Tomoko Yamagishi-Dressler, directrice marketing et administratrice d'Evolus, Inc. (EOLS), a d茅clar茅 avoir vendu 5聽722 actions ordinaires de la soci茅t茅 le 22/08/2025 au prix de 7,51 $ par action. Apr猫s la transaction, la personne d茅clarant d茅tenait b茅n茅ficiairement 89聽949 actions. Le d茅p么t indique que la vente a 茅t茅 effectu茅e conform茅ment 脿 un plan de transaction en vertu de la r猫gle 10b5-1 et que les actions vendues devaient l'锚tre pour couvrir des obligations fiscales r茅sultant de l'attribution de restricted stock units.
Formulaire et signature聽: Le formulaire Form 4 a 茅t茅 sign茅 par un mandataire agissant au nom de la personne d茅clarant et contient la formule de certification standard requise pour les d茅p么ts en vertu de la Section 16.
Insider-Verkauf nach 10b5-1-Plan: Tomoko Yamagishi-Dressler, Chief Marketing Officer und Direktorin von Evolus, Inc. (EOLS), meldete den Verkauf von 5.722 Stammaktien des Unternehmens am 22.08.2025 zu je $7,51. Nach der Transaktion hielt die meldende Person wirtschaftlich 89.949 Aktien. Die Meldung weist darauf hin, dass der Verkauf im Rahmen eines Rule 10b5-1-Handelsplans erfolgte und die verkauften Aktien zur Deckung von Steuerabzugsverpflichtungen aus dem Vesting von Restricted Stock Units verkauft werden mussten.
Formular und Unterschrift: Das Formular Form 4 wurde von einem Bevollm盲chtigten im Namen der meldenden Person ausgef眉hrt und enth盲lt die 眉blichen Best盲tigungsformulierungen, die f眉r Meldungen nach Section 16 erforderlich sind.
FAQ
What did Tomoko Yamagishi-Dressler report on Form 4 for EOLS?
Was the sale made under a 10b5-1 trading plan?
Why were the shares sold according to the filing?
What is the reporting person's role at Evolus (EOLS)?
Who signed the Form 4?
